Log In
Print
BCIQ
Print
Print this Print this
 

Binosto, Steovess, alendronate (EX101)

  Manage Alerts
Collapse Summary General Information
Company EffRx Pharmaceuticals S.A.
DescriptionAlendronate effervescent
Molecular Target Unknown
Mechanism of ActionUnknown
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentMarketed
Standard IndicationOsteoporosis
Indication DetailsTreat osteoporosis
Regulatory Designation

Partner

Abiogen Pharma S.p.A.; Ahn-Gook Pharmaceutical Co. Ltd.; Dara BioSciences Inc.; Hikma Pharmaceuticals plc; Laboratorios Atral S.A.; Merck & Co. Inc.; Mission Pharmacal Co.


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today